Retail Roundup

Date: 
Monday, December 5, 2016

This episode features David J. Fong, PharmD, former retail pharmacy senior executive who is now president of Dave Fong Rx Consulting, Inc., discussing trends and top opportunities likely to impact the retail pharmacy industry in the coming year, including:

  • DIR fees
  • Pharmacist provider status
  • Telehealth
  • Hospital-retail partnerships
  • Biosimilars
  • Opioid epidemic

Subscribe and Download this Podcast on iTunes

Visit iTunes Channel

You may also like:

Blog Post

Blockchain, the distributed ledger technology, continues to expand in the financial industry, but we haven’t yet examined its full potential to transform the healthcare industry. Healthcare, and the pharmacy industry specific...

View Blog Post
Blog Post

Pain management is an area of concern for many healthcare professionals, and not just because it’s so prevalent in the national news cycle. In her article “To tre...

View Blog Post
Blog Post

Because of the concern about prescription opioid abuse and the growing numbers of dependent opioid users switching to heroin, it is of interest to ascertain the rate and incidence of such transition. Accord...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up